FDA approves Vanda's Fanapt

Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) jumped $8.90 (824%) to $9.98 in early after-hours trading on Wednesday after FDA approved an NDA for Fanapt iloperidone to treat schizophrenia. Vanda...